✦ LIBER ✦

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease

✍ Scribed by M. A. SMITH; A. M. MARINAKI; M. ARENAS; M. SHOBOWALE-BAKRE; C. M. LEWIS; A. ANSARI; J. DULEY; J. D. SANDERSON

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective evaluation of the pharmacoge

✍ A. ANSARI; M. ARENAS; S. M. GREENFIELD; D. MORRIS; J. LINDSAY; K. GILSHENAN; M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Thiopurine methyl-transferase activity a

✍ Y. González-Lama; F. Bermejo; A. López-Sanromán; V. García-Sánchez; M. Esteve; J 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Cost-effectiveness of thiopurine methylt

✍ J. Winter; A. Walker; D. Shapiro; D. Gaffney; R. J. Spooner; P. R. Mills 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Long-term outcome of using allopurinol c

✍ A. ANSARI; T. ELLIOTT; B. BABURAJAN; P. MAYHEAD; J. O’DONOHUE; P. CHOCAIR; J. SA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB